| scholarly article | Q13442814 |
| P2093 | author name string | G. Kasai | |
| D. W. Luedke | |||
| M. N. Laham | |||
| R. A. Shildt | |||
| S. El-Beheri | |||
| P2860 | cites work | Cancer Research | Q326097 |
| Impaired immunoresponsiveness in tumor patients | Q39939888 | ||
| Antibody responses in normal infants and in infants receiving chemotherapy for congenital neuroblastoma | Q40097707 | ||
| Antibody response to influenza vaccination in renal transplant patients: correlation with allograft function | Q44710200 | ||
| Purified influenza virus vaccine. A study of viral reactivity and antigenicity | Q45810527 | ||
| Immunogenicity of Inactivated Influenza Virus Vaccine in Chronic Renal Failure | Q45815275 | ||
| Influenza immunization of adult patients with malignant diseases | Q50948355 | ||
| The antibody response in old age. | Q51055383 | ||
| Excess mortality from epidemic influenza, 1957-1966. | Q53680886 | ||
| Influenza in children and young adults with cancer.20 cases | Q67020617 | ||
| Response to Influenza Vaccine by Renal Transplant Patients | Q69355610 | ||
| Efficacy of "Hong Kong" vaccine in preventing "England" variant influenza A in 1972 | Q70002800 | ||
| PRODUCTION OF ANTIBODIES AGAINST VIRUSES IN LEUKAEMIA AND RELATED DISEASES | Q76878129 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oncology | Q162555 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 1629-1635 | |
| P577 | publication date | 1979-11-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Antibody response to influenza immunization in adult patients with malignant disease | |
| P478 | volume | 44 |
| Q33950824 | A comparison of cytomegalovirus and community respiratory viruses in immunocompromised patients |
| Q30413413 | A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients |
| Q45731339 | Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae |
| Q36478974 | Effect of 25‐hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients |
| Q34146495 | Efficacy of the influenza vaccine in patients with malignant lymphoma |
| Q30410465 | Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults |
| Q37004285 | Immunogenicity of Influenza Vaccination in Patients With Cancer |
| Q35705166 | Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancer |
| Q37416103 | Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses |
| Q28740919 | Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective |
| Q27027645 | Influenza vaccination in cancer patients undergoing systemic therapy |
| Q24202869 | Influenza vaccines in immunosuppressed adults with cancer |
| Q49500210 | Influenza vaccines in immunosuppressed adults with cancer |
| Q30385118 | Influenza vaccines: from surveillance through production to protection. |
| Q30421416 | Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemi |
| Q36620042 | Seroconversion after influenza vaccination in patients with lung cancer |
| Q24235812 | Vaccines for prophylaxis of viral infections in patients with hematological malignancies |
| Q24245832 | Vaccines for prophylaxis of viral infections in patients with hematological malignancies |
Search more.